Home / Community / News / News

News

01/23/2013 - 6:16pm

Methylphenidate, a psycho-stimulant drug, also known by its 1948 trademarked name of Ritalin, could be useful in the treatment of excessive daytime sleepiness (EDS) for DM1 patients, according to a recent study conducted by The Department of Human Genetics at the Centre Hospitalier Universitaire de Quebec in Quebec City, Canada.

01/23/2013 - 6:03pm

The Myotonic Dystrophy Foundation (MDF) is pleased to announce its most recent round of Fund-A-Fellow postdoctoral fellowship research grant awards. In January 2013, MDF awarded two $100,000 grants to postdoctoral Fellows working in universities and research facilities

10/23/2012 - 11:31am

A generic cardiovascular drug called mexiletine, initially developed to treat heart rhythm abnormalities, appears to hold some potential for treating muscle stiffness and other symptoms of non-dystrophic myotonias (NDMs),

05/16/2012 - 5:49pm

Antisense oligonucleotides – short segments of genetic material designed to target specific areas of a gene

05/16/2012 - 4:22pm

The new approach could have implications for many genetic diseases.

Partners

ExpansionTherapeutics.png

© Myotonic Dystrophy Foundation. All rights reserved.